{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360017290178465664.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.intimp.2020.106689"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1567576920314624?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1567576920314624?httpAccept=text/plain"}}],"dc:title":[{"@value":"Hypoxia-inducible factor-1: A potential pharmacological target to manage psoriasis"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380017290178465665","@type":"Researcher","foaf:name":[{"@value":"Wen-Jing Zhu"}]},{"@id":"https://cir.nii.ac.jp/crid/1380017290178465667","@type":"Researcher","foaf:name":[{"@value":"Ping Li"}]},{"@id":"https://cir.nii.ac.jp/crid/1380017290178465664","@type":"Researcher","foaf:name":[{"@value":"Ling Wang"}]},{"@id":"https://cir.nii.ac.jp/crid/1380017290178465666","@type":"Researcher","foaf:name":[{"@value":"Yang-Chun Xu"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"15675769"}],"prism:publicationName":[{"@value":"International Immunopharmacology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2020-09","prism:volume":"86","prism:startingPage":"106689"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","https://doi.org/10.15223/policy-017","https://doi.org/10.15223/policy-037","https://doi.org/10.15223/policy-012","https://doi.org/10.15223/policy-029","https://doi.org/10.15223/policy-004"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1567576920314624?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1567576920314624?httpAccept=text/plain"}],"createdAt":"2020-06-22","modifiedAt":"2026-01-21","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360580232172453504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Novel cell culture system for monitoring cells during continuous and variable negative‐pressure wound therapy"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.intimp.2020.106689"},{"@type":"CROSSREF","@value":"10.1111/srt.13262_references_DOI_QsMKakMVjEJcGDN1zuFM6AQEEXn"}]}